The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation.
 
Al Bowen Benson
Consulting or Advisory Role - Alchemia; Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; Genomic Health; Infinity Pharmaceuticals; Lilly/ImClone; Merck Serono; Merck/Schering Plough; National Cancer Institute; Pharmacyclics; Precision Therapeutics; Sanofi; Spectrum Pharmaceuticals; Taiho Pharmaceutical; Vicus Therapeutics
Research Funding - advanced accelerator applications; Alchemia; Amgen; Astellas Pharma; AVEO; Bayer/Onyx; EMD Serono (Inst); Genentech (I); Gilead Sciences; Infinity Pharmaceuticals; Merck Serono (Inst); Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals
 
Fengmin Zhao
No Relationships to Disclose
 
Neal J. Meropol
Patents, Royalties, Other Intellectual Property - VS 20020031515
 
Paul J. Catalano
Research Funding - Lilly/ImClone
 
Bapsi Chakravarthy
Research Funding - Bayer/Onyx (Inst)
 
Patrick J. Flynn
Employment - ARIAD (I)
Stock and Other Ownership Interests - ARIAD (I)
Speakers' Bureau - Celgene; Lilly; Novartis; Teva
 
Robert B. Catalano
No Relationships to Disclose
 
Bruce J. Giantonio
No Relationships to Disclose
 
Edith P. Mitchell
Honoraria - Sanofi
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst); sanofi (Inst)
 
Daniel G. Haller
Consulting or Advisory Role - Genentech; Halozyme; Targovax
Speakers' Bureau - Celgene; Taiho Pharmaceutical
 
Cynthia G. Leichman
Research Funding - Incyte (Inst)
 
Nicholas J. Petrelli
No Relationships to Disclose
 
Frank A. Sinicrope
Stock and Other Ownership Interests - Gilead Sciences; illumina
Consulting or Advisory Role - Ventana Medical Systems
Travel, Accommodations, Expenses - ventana medical systems
 
Joel E. Tepper
Consulting or Advisory Role - Natera
 
James D. Brierley
No Relationships to Disclose
 
Elin R. Sigurdson
No Relationships to Disclose
 
Richard M. Whittington
No Relationships to Disclose
 
Peter J. O'Dwyer
Consulting or Advisory Role - Bristol-Myers Squibb; Five Prime Therapeutics; Forty Seven; Genentech
Research Funding - BBI Healthcare; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Merck; Mirati Therapeutics; Novartis; Pfizer